Search Results 851-860 of 17813 for corticosteroid

1. A Study of the Effectiveness and Safety of Mongersen (GED-0301) for the Treatment of Patients with Active Crohn's Disease - Mayo Clinic

   Systemic corticosteroids; Immunosuppressants (eg, azathiopurine, 6-mercaptopurine, or methotrexate); Biologics for the treatment of CD. Exclusion Criteria. Any ...

2. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

   Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid release therapy for adrenal or pituitary insufficiency) is not considered a form of ...

3. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Corticosteroids; Immunomodulators; Tumor necrosis factor-alpha (TNFα) ... Oral corticosteroid therapy; Antidiarrheals for chronic diarrhea; Azathioprine ...

4. A Study of Budesonide Suspension in Adolescents and Adults with Eosinophilic Esophagitis Measuring Histologic Response and Decreased Dysphagia - Mayo Clinic

   Participant has been using swallowed topical corticosteroid for EoE or systemic corticosteroid ... corticosteroids based on the participant's usual ...

5. Bursitis Archives - Mayo Clinic News Network

   doctor for an evaluation. He or she may recommend a corticosteroid injection. This medication can help decrease inflammation and allow your knee to heal. A ...

6. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   ... corticosteroid therapy) and a dosage change is planned before Day 32. Note: topical agents and inhaled corticosteroid therapy use is permitted.

7. Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery - Mayo Clinic

   oral or parenteral corticosteroid use in the past 30 days; elevation of AST or ALT > 3x normal; elevation of creatinine kinase > 2x normal; previous adverse ...

8. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

   Corticosteroid therapy for 7 days prior to enrollment. Presence of any indwelling line or drain (e.g., percutaneous nephrostomy tube, indwelling Foley ...

9. A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

   Initiated low-dose corticosteroid ... Patients on a stable low-dose corticosteroid, bisphosphonate, or denosumab regimen are eligible and may continue treatment.

10. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... corticosteroids, immunosuppressants and/or biologic therapies, in the ... Oral corticosteroid dose > 30 mg/day (prednisone or equivalent) or has not ...